Legislation to deter brand-name pharmaceutical companies from blocking more affordable generic alternatives has been introduced in the Senate.
Sen Patrick Leahy (D, Vt) introduced the legislation under the act titled CREATES—Creating and Restoring Equal Access to Equivalent Samples—with Sen Chuck Grassley (R, Iowa), Sen Amy Klobuchar (D, Minn), and Sen Mike Lee (R, Utah).
“Our CREATES Act targets predatory delay tactics that some brand-name drug manufacturers are using to block competition from more affordable generic drugs,” Leahy, ranking member of the Senate Judiciary Committee, said in a recent statement (http://1.usa.gov/294CN9P).
Rubin R. Legislation to Increase Generic Drug Alternatives. JAMA. 2016;316(6):575. doi:10.1001/jama.2016.10615